|
[745] Brown, S.K. and Cheng, M., 2000. Volatile Organic Compounds (VOCs) in New Car Interiors. Presented at the 35th International Clean Air & Environment Conference Sydney, 26–30 November 2000. [746] http://www.le.ac.uk/ieh [747] Clapp, R.W. and others, 2005. Environmental and occupational causes of cancer . The Lowell Centre for Sustainable Production, University of Massachusetts Lowell. [748] The Globe and Mail, November 22, 2002, page A5. Data point to breast-cancer risk. By Martin Mittelstaedt. [749] Newby, J.A. and Howard, C.V., 2006. Environmental influences in cancer aetiology. Journal of Nutritional and Environmental Medicine; 2006, 1-59. [750] Clapp, R.W. and others, 2005. Environmental and occupational causes of cancer . The Lowell Centre for Sustainable Production, University of Massachusetts Lowell. [751] Birnbaum, L.S. and Fenton, S.E., 2003. Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives , 11 (4), 389–395. [752] www.obgyn.nct/newsrx/womens_health-Colorectal_Cancer-20001214-7.asp [753] http://info.cancerresearchuk.org/healthyliving/dietandhealthycating/theepicstudy [754] www.ucdmc.ucdavis.edu/ucdhs/health/a-z/06BreastCancer/doc06lowerisk.html [755] Epidem. 1994, 23 (6), 1133–1136. [756] Spurgeon, D., 2006. Vitamin D is associated with a lower risk of cancer. BMJ , 332, 70. [757] Miller, W.R. and Sharpe, R.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer , 5, 69–96. [758] http://cis.nci.nih.gov/fact/3_13.htm [759] Gottlieb, Scott. 2002. Study supports evidence on oral contraception and breast cancer. BMJ , 325, 6 July 2002, 8. [760] Writing Group for the Women's Health Initiative Investigators. 2002. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Journal of the American Medical Association , 288, № 3. [761] Collaborative Group on Hormonal Factors in Breast Cancer, 1997. Breast cancer and hormone replacement therapy. Lancet , 350, 1047–1059. [762] Schairer, C., Lubin, J., Troisi, R., and others, 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA , 283(4), 485–491. [763] www.nih.gov/news/pr/nov2002/nichd-29.htm [764] Ross, R.K., Paganini-Hill, A., Wan, P.C. and others, 2000. Effective hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl Cancer Inst , 92, 328–332. Schairer, C., Lubin, J., Troisi, R. and others. 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA , 283 (4), 485–491. — 388 —
|